M.A. SUKOYAN; A.Y. KERKIS; M.R.B. MELLO; I.E. KERKIS; J.A. VISINTIN; L.V. PEREIRA. Establishment of new murine embryonic stem cell lines for the generation of mouse models of human genetic diseases. Brazilian Journal of Medical and Biological Research, v. 35, n. 5, p. 535-542, Maio 2002. (98/10607-8, 98/10703-7, 98/10606-1)
GYURICZA, ISABELA GERDES; DE SOUZA, RODRIGO BARBOSA; FARINHA-ARCIERI, LUIS ERNESTO; FERNANDES, GUSTAVO RIBEIRO; PEREIRA, LYGIA VEIGA. Is HSPG2 a modifier gene for Marfan syndrome?. European Journal of Human Genetics, v. 28, n. 9, JUN 2020. Citações Web of Science: 0. (16/16077-0, 18/11708-8, 16/18255-3)
WHITE, TOMAS L.; LEWIS, PHILIP; HAYES, SALLY; FERGUSSON, JAMES; BELL, JAMES; FARINHA, LUIS; WHITE, NICK S.; PEREIRA, LYGIA V.; MEEK, KEITH M.. The Structural Role of Elastic Fibers in the Cornea Investigated Using a Mouse Model for Marfan Syndrome. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, v. 58, n. 4, p. 2106-2116, APR 2017. Citações Web of Science: 8. (11/01477-0)
MOREIRA DE MELLO, JOANA C.; FERNANDES, GUSTAVO R.; VIBRANOVSKI, MARIA D.; PEREIRA, LYGIA V.. Early X chromosome inactivation during human preimplantation development revealed by single-cell RNA-sequencing. SCIENTIFIC REPORTS, v. 7, SEP 7 2017. Citações Web of Science: 21. (15/20844-4, 09/17481-6, 15/03610-0, 13/08135-2)
HE, NANNAN; LIM, SHUJING J.; MOREIRA DE MELLO, JOANA C.; NAVARRO, INJERREAU; BIALECKA, MONIKA; SALVATORI, DANIELA C. F.; VAN DER WESTERLAKEN, LUCETTE A. J.; PEREIRA, LYGIA V.; LOPES, SUSANA M. CHUVA DE SOUSA. At Term, XmO and XpO Mouse Placentas Show Differences in Glucose Metabolism in the Trophectoderm-Derived Outer Zone. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, v. 5, 2017. Citações Web of Science: 1. (09/17481-6, 15/03610-0, 13/08135-2)
SARAFIAN, RAQUEL; MORATO-MARQUES, MARIANA; BORSOI, JULIANA; PEREIRA, LYGIA VEIGA. Monitoring cell line identity in collections of human induced pluripotent stem cells. STEM CELL RESEARCH, v. 28, p. 66-70, APR 2018. Citações Web of Science: 0. (16/16076-4, 16/20650-8, 13/08135-2)